FDA.reportPublic FDA data

Ceftriaxone Sodium

Product NDC
60505-6149
11-digit product format
605056149
Labeler code
60505
Product ID
60505-6149_0432e6c3-ad77-726c-e063-6294a90a798c
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Ceftriaxone Sodium
Dosage form
INJECTION, POWDER, FOR SOLUTION
Route
INTRAMUSCULAR; INTRAVENOUS
Labeler
Apotex Corp.
Application
ANDA203702
Marketing category
ANDA
Marketing start
2017-06-30
Substance
CEFTRIAXONE SODIUM
Active strength
2 g/1
Pharmacologic classes
Cephalosporin Antibacterial [EPC], Cephalosporins [CS]
NDC exclude flag
No
Listing certified through
2026-12-31
Current FDA listing
Yes

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
67ae10d0-6c6a-4d52-a629-da83321859b9Product name320190201
01b0d089-049b-4c6d-8dfe-1bffad9be307Product name220180807
2d5083fe-71de-4fce-8d67-e9049cba775cProduct name120150107
1037f4ca-3bea-c9c4-2af4-fa6387b0e81eProduct name120140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
60505-6149-0Ceftriaxone Sodium1 in 1 VIAL, SINGLE-USEINJECTION, POWDER, FOR SOLUTION111
60505-6149-4Ceftriaxone Sodium10 in 1 CARTONINJECTION, POWDER, FOR SOLUTION1011

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
60505-6149-0EA - Each60505-61492fc4a6a1-eadb-4a99-9563-3cd5033f3fbb12017-07-07
60505-6149-4EA - Each60505-61496e5b364c-8e9b-41a4-91dd-4b96aacdc12c12017-07-07

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
60505-6149CEFTRIAXONE SODIUM INJECTION, POWDER, FOR SOLUTION [APOTEX CORP.]11Current NDC, Legacy NDC, 2 package rows20230831_5116231f-82d1-44be-b08e-560c9a50e5c5.zip

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
1665021cefTRIAXone 1 GM InjectionPSN5116231f-82d1-44be-b08e-560c9a50e5c511
1665046cefTRIAXone 2 GM InjectionPSN5116231f-82d1-44be-b08e-560c9a50e5c511
309092cefTRIAXone 250 MG InjectionPSN5116231f-82d1-44be-b08e-560c9a50e5c511
1665005cefTRIAXone 500 MG InjectionPSN5116231f-82d1-44be-b08e-560c9a50e5c511
1665021ceftriaxone 1000 MG InjectionSCD5116231f-82d1-44be-b08e-560c9a50e5c511
1665046ceftriaxone 2000 MG InjectionSCD5116231f-82d1-44be-b08e-560c9a50e5c511
309092ceftriaxone 250 MG InjectionSCD5116231f-82d1-44be-b08e-560c9a50e5c511
1665005ceftriaxone 500 MG InjectionSCD5116231f-82d1-44be-b08e-560c9a50e5c511
1665021ceftriaxone 1 GM (as ceftriaxone sodium) InjectionSY5116231f-82d1-44be-b08e-560c9a50e5c511
1665046ceftriaxone 2 GM (as ceftriaxone sodium) InjectionSY5116231f-82d1-44be-b08e-560c9a50e5c511
309092ceftriaxone 250 MG (as ceftriaxone sodium) InjectionSY5116231f-82d1-44be-b08e-560c9a50e5c511
1665005ceftriaxone 500 MG (as ceftriaxone sodium) InjectionSY5116231f-82d1-44be-b08e-560c9a50e5c511

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionMarketing startMarketing endSampleExclude flagStatus
60505-6149-0605056149001 in 1 VIAL, SINGLE-USEHistorical
60505-6149-46050561490410 VIAL, SINGLE-USE in 1 CARTON (60505-6149-4) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-USE (60505-6149-0) 2017-06-300000-00-00NoNoCurrent